Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Felsenberg

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Journal of Musculoskeletal & Neuronal Interactions|December 2, 2009
Age-dependency in bone mass and geometry: a pQCT study on male and female master sprinters, middle and long distance runners, race-walkers and sedentary peopleD C Wilks, K Winwood, S F Gilliver, et al.
Developmental Biology|July 6, 2010
Severe developmental bone phenotype in ClC-7 deficient miceA V Neutzsky-Wulff, N A Sims, C Supanchart, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Osteoporosis in the male]B Allolio, M Dambacher, R Dreher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 23, 2011
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyS L Silverman, A A Chines, D L Kendler, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 2, 2017
T2-relaxation time increases in lumbar intervertebral discs after 21d head-down tilt bed-restT Koy, B Ganse, J Zange, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 3, 2011
Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone massD Felsenberg, O Bock, H Börst, et al.
Bone|April 1, 2009
Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: a pQCT studyD C Wilks, K Winwood, S F Gilliver, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2007
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosisS Adami, J San Martin, M Muñoz-Torres, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 7, 1999
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study GroupH A Pols, D Felsenberg, D A Hanley, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Journal of Musculoskeletal & Neuronal Interactions|December 2, 2009
Age-dependency in bone mass and geometry: a pQCT study on male and female master sprinters, middle and long distance runners, race-walkers and sedentary peopleD C Wilks, K Winwood, S F Gilliver, et al.
Developmental Biology|July 6, 2010
Severe developmental bone phenotype in ClC-7 deficient miceA V Neutzsky-Wulff, N A Sims, C Supanchart, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2000
[Osteoporosis in the male]B Allolio, M Dambacher, R Dreher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 23, 2011
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyS L Silverman, A A Chines, D L Kendler, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 2, 2017
T2-relaxation time increases in lumbar intervertebral discs after 21d head-down tilt bed-restT Koy, B Ganse, J Zange, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 3, 2011
Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone massD Felsenberg, O Bock, H Börst, et al.
Bone|April 1, 2009
Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: a pQCT studyD C Wilks, K Winwood, S F Gilliver, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2007
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosisS Adami, J San Martin, M Muñoz-Torres, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2013
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in menJ-M Kaufman, M Audran, G Bianchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 7, 1999
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study GroupH A Pols, D Felsenberg, D A Hanley, et al.
Pageof 19